MeiraGTx Holdings (MGTX) Intangibles (2020 - 2026)
MeiraGTx Holdings' (MGTX) quarterly Intangibles came in at $578000.0 in Q4 2025, down 29.6% YoY from $821000.0 in Q4 2024, and down 11.49% on a QoQ basis from $653000.0 in Q3 2025.
Analysis
MeiraGTx Holdings (MGTX) Intangibles (2020 - 2026) Analysis & Trends
MeiraGTx Holdings (MGTX) has 6 years of Intangibles data on file, last reported at $578000.0 in Q4 2025.
- Quarterly Intangibles fell 29.6% year-over-year to $578000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $578000.0 (down 29.6% YoY) and the FY2025 annual result came in at $578000.0, down 29.6% from the prior year.
- Intangibles slipped to $578000.0 in Q4 2025, from $653000.0 in the prior quarter.
- In the past five years, Intangibles ranged from a high of $2.1 million in Q1 2021 to a low of $578000.0 in Q4 2025.
- A 5-year average of $1.2 million and a median of $1.2 million in 2023 frame the typical range for Intangibles.
- Annual changes were most pronounced in 2023 — Intangibles declined 11.83% — and 2025, when it tumbled 31.34%.
- Tracing MGTX's Intangibles over 5 years: stood at $1.8 million in 2021, then decreased by 25.46% to $1.3 million in 2022, then retreated by 16.25% to $1.1 million in 2023, then retreated by 26.57% to $821000.0 in 2024, then fell by 29.6% to $578000.0 in 2025.
- The last three Intangibles figures came in at $578000.0 (Q4 2025), $653000.0 (Q3 2025), and $742000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 63.28 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 60.96 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 93.49 Mn |
| 10 | MeiraGTx Holdings | 1.27 Bn | 1.13 Bn | 315.67 Mn | 421,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 421,000.00 |
| Dec 31, 2025 | 578,000.00 |
| Sep 30, 2025 | 653,000.00 |
| Jun 30, 2025 | 742,000.00 |
| Mar 31, 2025 | 773,000.00 |
| Dec 31, 2024 | 821,000.00 |
| Sep 30, 2024 | 951,000.00 |
| Jun 30, 2024 | 969,000.00 |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 1.12 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.34 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 1.67 Mn |
| Dec 31, 2021 | 1.79 Mn |
| Sep 30, 2021 | 1.86 Mn |
| Jun 30, 2021 | 1.99 Mn |